Ergoteles’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-7,023	Closed	-$839K	–	1591
2022 Q4	$839K	Buy	+7,023	New	+$839K	0.03%	524
2022 Q3	–	Sell	-14,190	Closed	-$1.38M	–	1834
2022 Q2	$1.38M	Buy	+14,190	New	+$1.38M	0.04%	416